The pharmacy benefit management market would grow at a CAGR of 5.5% over the predicted time frame. The market is expected to increase in value from US$ 493.3 Bn in 2022 to US$ 757.05 Bn in 2030.
The on pharmacy
benefit management Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1770
Report Scope of the Pharmacy Benefit Management Market
| Report Coverage | Details |
| Market Size by 2030 | USD 757.05 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.5% |
| Largest Market | Asia Pacific |
| Fastest Growing Region | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Service, Service Provider, Business Model, Region |
A recent
report provides crucial insights along with application based and forecast
information in the Global Pharmacy benefit management Market. The report
provides a comprehensive analysis of key factors that are expected to drive the
growth of this market. This study also provides a detailed overview of the
opportunities along with the current trends observed in the Pharmacy benefit
management market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Pharmacy benefit
management market are included as given below:
Pharmacy benefit management Market Key Players
- CVS Health
- SS&C Technologies, Inc.
- Anthem Inc.
- Medimpact
- Express Scripts Holding Company
- Benecard Services, LLC
- CaptureRx Inc.
- Change Healthcare
- OptumRx, Inc.
- Cigna
Market Segments
- Specialty Pharmacy Services
- Benefit Plan Design & Administration
- Formulary Management
- Pharmacy Claims Processing
- Others
By Service Provider
- Retail Pharmacies
- Insurance Companies
- Standalone Pharmacy Benefit Management Providers
By Business Model
- Government Health Programs
- Employer-sponsored Programs
- Health Insurance Management
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global pharmacy
benefit management market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the pharmacy
benefit management market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmacy Benefit Management Market
5.1. COVID-19 Landscape: Pharmacy Benefit Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmacy Benefit Management Market, By Service
8.1. Pharmacy Benefit Management Market, by Service, 2022-2030
8.1.1 Specialty Pharmacy Services
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Benefit Plan Design & Administration
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Formulary Management
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Pharmacy Claims Processing
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmacy Benefit Management Market, By Service Provider
9.1. Pharmacy Benefit Management Market, by Service Provider, 2022-2030
9.1.1. Retail Pharmacies
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Insurance Companies
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Standalone Pharmacy Benefit Management Providers
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmacy Benefit Management Market, By Business Model
10.1. Pharmacy Benefit Management Market, by Business Model, 2022-2030
10.1.1. Government Health Programs
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Employer-sponsored Programs
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Health Insurance Management
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Pharmacy Benefit Management Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Business Model (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Business Model (2017-2030)
Chapter 12. Company Profiles
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SS&C Technologies, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Anthem Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medimpact
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Express Scripts Holding Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Benecard Services, LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CaptureRx Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Change Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OptumRx, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Cigna
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments